Carregando...
Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of 6 Prospective Trials
BACKGROUND: Carbohydrate antigen 19-9 (CA19-9) is a widely used biomarker in pancreatic cancer. There is no consensus on the interpretation of the change in CA19-9 serum levels and its role in the clinical management of patients with pancreatic cancer. METHODS: Individual patient data from 6 prospec...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261189/ https://ncbi.nlm.nih.gov/pubmed/22786786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27734 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|